Background
postoperative pain, astigmatism, Keratoconus, Corneal crosslinking, lens, keratoconus, photophobia
CORNEAL ECTASIA, DISEASE PROGRESSION, INFILTRATION, ASTIGMATISM, DISEASE, KERATOCONUS, CORNEA, LENS, KERATOCONUS
Keratoconus is a bilateral asymmetrical ophthalmological disease accompanied by progressive corneal ectasia. The major clinical characteristics are substantial thinning and bulging of the cornea, as well as astigmatism to various extents, resulting in a rapid reduction in visual acuity.The prevalence and incidence rates are approximately 1:375, and are distributed globally [Corneal crosslinking (CXL) is regarded as an effective clinical treatment for preventing disease progression [Although the corneal epithelial layer is untouched during transepithelial CXL procedures, topical destruction caused by riboflavin infiltration and UV light exposure may lead to postoperative pain, photophobia, and foreign body sensation in patients [The main component of the silicon hydrogel (SiH) corneal contact lens is silicone hydrogel, containing 38% hydrogen, a diameter of 14 mm, with base curve 8.8 mm, and corneal central thickness of 0.07 mm [The US Food and Drug Administration (FDA) has approved the overnight use or continuous wearing of contact lenses as part of the treatment of keratoconus [Therefore, in this study, we investigated the impact of contact lens application after transepithelial CXL to analyze whether the patient’s overall comfort is related to the duration of lens wearing and to further evaluate patient satisfaction based on the attained ophthalmologic evidence.